Clinical trial Recruiting at 8 sites Observational Ages 2 and up

Long-term performance and safety of Biodentine™ XP for coronal restorations and endodontic treatments

Official title: Observational, Prospective, International and Multicenter Clinical Investigation Measuring the Longterm Clinical Performance and Safety of Biodentine™ XP in Patients Treated for Coronal Restorative or Endodontic Dental Indications.

Run by Septodont · NCT06955429 · Data updated 2026-11-12

This project will test whether Biodentine™ XP works well and stays safe for up to 10 years when used to repair and treat teeth in children and adults.

More Dental Restoration, Permanent trials

Quick facts

Study typeObservational
Ages2 Years and up
SexAll
Enrollment275 (estimated)
SponsorSeptodont
Industry-sponsored
Locations8 sites (Kraainem and 7 other locations)
StatusRecruiting
StartedOctober 23, 2025
Main results expectedFebruary 29, 2032
Study endsFebruary 28, 2037
Registry record updatedMay 6, 2026
Trial IDNCT06955429 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children (age ≥2) and adults with temporary or permanent teeth needing coronal restorative or endodontic treatment where the clinician plans to use Biodentine™ XP.

Probably not a fit

Patients with documented contraindications to Biodentine™ XP, those whose treated tooth is unlikely to survive the required follow‑up period, or those with relevant uncontrolled systemic disease may not receive benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational, multicenter post‑market follow‑up collecting up to 10 years of clinical performance and safety data for Biodentine™ XP in coronal restorative and endodontic indications. Patients receive routine dental care with Biodentine™ XP according to the device's CE‑marked instructions for use, and no additional invasive procedures are required beyond standard treatment and follow‑up. Investigators are experienced general dental practitioners and pediatric dentists at centers in France and Belgium. Outcomes include treatment success, tooth survival, and device‑related adverse events in a real‑world setting.

Why it matters

Potential benefit: If successful, the findings could confirm long-term durability and safety of Biodentine™ XP, giving dentists and patients greater confidence in its use for restorations and endodontic repairs.

How similar studies have gone: Prior clinical and post‑marketing reports on Biodentine formulations have shown favorable short‑to‑medium‑term outcomes, but long‑term prospective data up to 10 years remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Temporary tooth, from a child ≥ 2 years old, requiring dental restorative treatment with Biodentine™ XP, and/or, Permanent (mature or immature) tooth, from a child or an adult, requiring a dental restorative and/or an endodontic treatment with Biodentine™ XP.
2. Adult patient with a signed informed consent form; For the minor, if in age to understand, an assent is required, and at least one parent or legal representative must consent.
3. Only in France: Subject affiliated or benefiting from a social/health insurance system.

Exclusion Criteria:

1. Patient with one or more documented contraindication to use Biodentine™ XP (Refer to IFU).
2. Inadequate expected tooth lifetime as estimated by the investigator:

   * For a Temporary tooth: high probability of tooth loss within 2 years after treatment with Biodentine™ XP.
   * For a permanent tooth: high probability of tooth loss within 10 years after treatment with Biodentine™ XP.
3. Patient with any systemic disease that may hinder the normal healing process and/or the follow-up.
4. Adult patient under legal protection measures or unable to express his/her consent, and individual deprived of liberty by judicial or administrative decision, as well as individual receiving psychiatric care.
5. Periodontitis (stage 3, 4 or stage 2 grade C).
6. Inability to comply with study procedures.
7. Participation in another interventional clinical investigation that can induce bias in the study results.

Where it's running

  • Queen Astrid Dental Practice
    Kraainem, Belgium
    Recruiting
  • UZ Leuven - University hospital
    Leuven, Belgium
    Recruiting
  • HCL Lyon
    Lyon, France
    Recruiting
  • Cabinet dentaire
    Nantes, France
    Recruiting
  • Cabinet dentaire
    Paris, France
    Recruiting
  • Hôpital Rotschild
    Paris, France
    Recruiting
Show 2 more locations
  • Hôpital Pitié Salpêtrière
    Paris, France
    Recruiting
  • CHU Rennes
    Rennes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.